What is the share price of Max Healthcare Institute Ltd (MAXHEALTH) today?
The share price of MAXHEALTH as on 20th March 2026 is ₹964.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max Healthcare Institute Ltd (MAXHEALTH) share?
The past returns of Max Healthcare Institute Ltd (MAXHEALTH) share are- Past 1 week: -5.04%
- Past 1 month: -10.95%
- Past 3 months: -10.32%
- Past 6 months: -17.65%
- Past 1 year: -15.06%
- Past 3 years: 106.07%
- Past 5 years: 372.83%
What are the peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH)?
The peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH) include:What is the dividend yield % of Max Healthcare Institute Ltd (MAXHEALTH) share?
The current dividend yield of Max Healthcare Institute Ltd (MAXHEALTH) is 0.16.What is the market cap of Max Healthcare Institute Ltd (MAXHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max Healthcare Institute Ltd (MAXHEALTH) is ₹92749.50 Cr as of 20th March 2026.What is the 52 week high and low of Max Healthcare Institute Ltd (MAXHEALTH) share?
The 52-week high of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1314.30 and the 52-week low is ₹933.80.What is the PE and PB ratio of Max Healthcare Institute Ltd (MAXHEALTH) stock?
The P/E (price-to-earnings) ratio of Max Healthcare Institute Ltd (MAXHEALTH) is 86.21. The P/B (price-to-book) ratio is 9.89.Which sector does Max Healthcare Institute Ltd (MAXHEALTH) belong to?
Max Healthcare Institute Ltd (MAXHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max Healthcare Institute Ltd (MAXHEALTH) shares?
You can directly buy Max Healthcare Institute Ltd (MAXHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max Healthcare Institute Ltd
MAXHEALTH Share Price
NSE₹964.801.23% (+11.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MAXHEALTH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MAXHEALTH Performance & Key Metrics
MAXHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 65.35 | 9.89 | 0.16% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.10 | 5.54 | 0.61% |
82%
Analysts have suggested that investors can buy this stock
from 22 analysts
Price Upside
Earnings Growth
Rev. Growth
MAXHEALTH Company Profile
Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.
APOLLOHOSP
PE Ratio
72.12
72.12
1Y Return
13.75%
13.75%
Buy Reco %
86.21
86.21
FORTIS
PE Ratio
79.80
79.80
1Y Return
31.04%
31.04%
Buy Reco %
82.35
82.35
PE Ratio
42.37
42.37
1Y Return
1.99%
1.99%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.12
6.12
1Y Return
44.64%
44.64%
Buy Reco %
100.00
100.00
MEDANTA
PE Ratio
56.61
56.61
1Y Return
18.87%
18.87%
Buy Reco %
73.33
73.33
MAXHEALTH Sentiment Analysis
MAXHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MAXHEALTH Stock Summary · November 2025
Max Healthcare demonstrated robust financial performance in Q2 FY26, achieving a 21% year-on-year revenue growth and a 23% increase in operating EBITDA, despite facing operational challenges such as fluctuating occupancy rates and increased net debt from capacity expansions. The company is strategically focused on enhancing its healthcare infrastructure through brownfield expansions and the commissioning of new facilities, which are expected to improve revenue and operational efficiency. Notably, digital revenue and international patient segments are emerging as significant growth drivers, while the anticipated positive impact from the Central Government Health Scheme is set to bolster future earnings. However, the competitive landscape and the need for effective capacity management remain critical as the company navigates its growth trajectory. Overall, the outlook remains cautiously optimistic, with expectations for improved margins and profitability as new projects stabilize.
MAXHEALTH Stock Growth Drivers
MAXHEALTH Stock Growth Drivers
8Strong Financial Performance
The company reported a robust financial performance with a 21% year-on-year revenue growth in Q2
Operational Expansion and Capacity Enhancement
The company is actively enhancing its operational capacity through brownfield expansions, with new facilities being
MAXHEALTH Stock Challenges
MAXHEALTH Stock Challenges
6Occupancy Challenges
The average occupancy for the network has decreased from 79% to 77% year-on-year, indicating a
ARPOB Growth Concerns
There are concerns regarding the growth rate of Average Revenue Per Occupied Bed (ARPOB), which
MAXHEALTH Forecast
MAXHEALTH Forecasts
Price
Revenue
Earnings
MAXHEALTH Share Price Forecast
MAXHEALTH Share Price Forecast
2026
Current
₹964.80
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹964.80
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH Company Revenue Forecast
MAXHEALTH Company Revenue Forecast
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH
MAXHEALTH
Income
Balance Sheet
Cash Flow
Quarterly Normal View
MAXHEALTH Income Statement
MAXHEALTH Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,408.64 | 1,380.99 | 1,468.15 | 1,577.63 | 1,748.30 | 1,901.61 | 1,956.66 | 2,064.08 | 2,168.37 | 2,112.90 | ||||||||||
Operating & Other expenses | 975.81 | 949.11 | 1,041.37 | 1,155.54 | 1,256.92 | 1,442.81 | 1,398.12 | 1,504.66 | 1,560.32 | 1,577.42 | ||||||||||
EBITDA | 432.83 | 431.88 | 426.78 | 422.09 | 491.38 | 458.80 | 558.54 | 559.42 | 608.05 | 535.48 | ||||||||||
| Depreciation/Amortization | 57.88 | 60.96 | 70.32 | 76.90 | 84.15 | 97.54 | 100.83 | 104.14 | 108.10 | 111.27 | ||||||||||
| PBIT | 374.95 | 370.92 | 356.46 | 345.19 | 407.23 | 361.26 | 457.71 | 455.28 | 499.95 | 424.21 | ||||||||||
| Interest & Other Items | 8.53 | 11.24 | 20.73 | 23.88 | 33.54 | 52.39 | 55.21 | 54.85 | 53.92 | 59.67 | ||||||||||
| PBT | 366.42 | 359.68 | 335.73 | 321.31 | 373.69 | 308.87 | 402.50 | 400.43 | 446.03 | 364.54 | ||||||||||
| Taxes & Other Items | 89.74 | 70.34 | 84.19 | 85.04 | 91.88 | 70.07 | 83.50 | 92.46 | -45.27 | 63.62 | ||||||||||
| Net Income | 276.68 | 289.34 | 251.54 | 236.27 | 281.81 | 238.80 | 319.00 | 307.97 | 491.30 | 300.92 | ||||||||||
| EPS | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.10 |
MAXHEALTH Company Updates
FY 2026FY 2026
Investor Presentation
Feb 20PDF
Feb 7PDF
Nov 19PDF
+2 more
MAXHEALTH Stock Peers
MAXHEALTH Past Performance & Peer Comparison
MAXHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max Healthcare Institute Ltd | 86.21 | 9.89 | 0.16% |
| Apollo Hospitals Enterprise Ltd | 72.12 | 9.40 | 0.17% |
| Fortis Healthcare Ltd | 79.80 | 6.74 | 0.12% |
| Narayana Hrudayalaya Ltd | 42.37 | 9.23 | 0.27% |
MAXHEALTH Stock Price Comparison
Compare MAXHEALTH with any stock or ETFCompare MAXHEALTH with any stock or ETF
MAXHEALTH
MAXHEALTH Holdings
MAXHEALTH Shareholdings
MAXHEALTH Promoter Holdings Trend
MAXHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MAXHEALTH Institutional Holdings Trend
MAXHEALTH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.25%
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding History
MAXHEALTH Shareholding History
Foreign Institutions
Mutual Funds Invested in MAXHEALTH
Mutual Funds Invested in MAXHEALTH
No mutual funds holding trends are available
Top 5 Mutual Funds holding Max Healthcare Institute Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8241% | Percentage of the fund’s portfolio invested in the stock 0.93% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/133 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7417% | Percentage of the fund’s portfolio invested in the stock 1.56% | Change in the portfolio weight of the stock over the last 3 months -0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 53/103 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7270% | Percentage of the fund’s portfolio invested in the stock 7.18% | Change in the portfolio weight of the stock over the last 3 months 1.50% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/49 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MAXHEALTH stock
smallcases containing MAXHEALTH stock
Looks like this stock is not in any smallcase yet.
MAXHEALTH Events
MAXHEALTH Events
MAXHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MAXHEALTH Dividend Trend
No dividend trend available
MAXHEALTH Upcoming Dividends
MAXHEALTH Upcoming Dividends
No upcoming dividends are available
MAXHEALTH Past Dividends
MAXHEALTH Past Dividends
Cash Dividend
Ex DateEx DateJul 4, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 4, 2025
Cash Dividend
Ex DateEx DateAug 23, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2023
MAXHEALTH Stock News & Opinions
MAXHEALTH Stock News & Opinions
Articles & Videos
Corporate
Max Healthcare Institute allots 42,266 equity shares under ESOS
Max Healthcare Institute has allotted 42,266 equity shares under ESOS on 17 March 2026. With this allotment, the paid up equity share capital has increased to 97,31,35,041 equity shares of Rs 10 each. Powered by Capital Market - Live
3 days agoCapital Market - Live
Earnings
Max Healthcare Institute consolidated net profit rises 26.01% in the December 2025 quarter
Net profit of Max Healthcare Institute rose 26.01% to Rs 300.92 crore in the quarter ended December 2025 as against Rs 238.80 crore during the previous quarter ended December 2024. Sales rose 10.66% to Rs 2067.52 crore in the quarter ended December 2025 as against Rs 1868.31 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2067.521868.31 11 OPM %26.0426.72 - PBDT524.05480.04 9 PBT412.78382.50 8 NP300.92238.80 26 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Max Healthcare Institute approves amendment to services agreement for additional beds at Max Dwarka
The board of Max Healthcare Institute at its meeting held on 05 February 2026 has approved the amendment to the existing services agreement to extend the current arrangement to ~260 additional beds being constructed by Muthoot Hospitals at the same site where 300-bedded Max Super Speciality Hospital, Dwarka (Max Dwarka) is presently operational.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Max Healthcare Institute grants 2.84 lakh stock options under ESOS
Max Healthcare Institute has approved grant of 2,84,520 stock options to eligible employees under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Max Healthcare Institute allots 91,317 equity shares under ESOS
Max Healthcare Institute has allotted 91,317 equity shares under ESOS on 04 February 2026. With this allotment, the paid up equity share capital has increased to 97,30,92,775 equity shares of Rs 10 each. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Max Healthcare Institute announces board meeting date
Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Max Healthcare Institute allots 2.32 lakh equity shares under ESOS
Max Healthcare Institute has allotted 2,32,104 equity shares under ESOS on 02 January 2026. With this allotment, the paid up equity share capital has increased to Rs 973,00,14,580 comprising of 97,30,01,458 equity shares of Rs 10 each. Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Max Healthcare Institute to set up 450-bed super speciality hospital in Pune
Max Healthcare Institute announced its entry into Pune with a 450-beds super speciality hospital, involving an investment of over Rs 1000 crore. The state-of-the-art facility, situated in Yerawada, Pune'one of the city's prime and centrally located areas, is expected to be commissioned over the next 3 years. The hospital, will mark Max Healthcare's fourth facility in Western India, further strengthening Max Healthcare's presence in Maharashtra. The transaction involves staggered acquisition of a 100% equity stake in Yerawada Properties (YPPL), Pune and further development of the hospital over the course of next 3 years. Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Max Healthcare rises after deal to acquire freehold land in Pune for proposed 450-bed hospital
Yerawada Properties is engaged in real estate development business and owns 1.68 acres parcel of freehold land located in Yerawada, Pune, a prime locality in the centre of the city. The land has the capacity to accommodate development of a 450 bedded hospital. The acquisition of YPPL will lead to expansion of company's footprint in Maharashtra by enabling setting up of a hospital in Yerawada, Pune. The purchase of equity stake shall be carried out in a step-up manner and shall conclude upon receipt of occupancy certificate for the hospital building planned to be constructed on the said land. In the first tranche, the company shall acquire 100% of the class-A equity shares representing 100% of the voting rights and nearly 50.22% of the economic interest in YPPL. Further, the company shall acquire 100% class-B equity shares in a phased manner over a period of 4 years. The board of Max Healthcare has also accorded its approval for setting up a 450 bedded super speciality hospital on the land owned by YPPL, at an aggregate spend of up to Rs 1,020 crore (including YPPL shares acquisition, construction, equipment cost, stamp duty, registration charges, etc.). Max Healthcare Institute (Max Healthcare) is one of India's largest healthcare organizations. The company operates 20 healthcare facilities (nearly 5,200 beds) with a significant presence in North India. In addition to the hospitals, Max Healthcare operates homecare and pathology businesses under brand names Max@Home and Max Lab, respectively. The company had reported a 59% rise in net profit to Rs 554 crore on a 21% increase in net revenue to Rs 2,580 crore in Q2 FY26 as compared with Q2 FY25. Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Max Healthcare Institute consolidated net profit rises 74.34% in the September 2025 quarter
Net profit of Max Healthcare Institute rose 74.34% to Rs 491.30 crore in the quarter ended September 2025 as against Rs 281.81 crore during the previous quarter ended September 2024. Sales rose 25.07% to Rs 2135.47 crore in the quarter ended September 2025 as against Rs 1707.46 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2135.471707.46 25 OPM %26.9326.39 - PBDT554.13457.84 21 PBT446.03373.69 19 NP491.30281.81 74 Powered by Capital Market - Live
4 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 45.36%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 2.66% to 8.72%
Over the last 5 years, net income has grown at a yearly rate of 78.73%, vs industry avg of 42.46%